Research Roundup

Debbie Rigby rounds up the latest in research news Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of NOACs in patients with atrial fibrillation A meta-analysis of 15 studies has shown higher bleeding and mortality risks in NOAC-treated AF patients concomitantly using P-gp/CYP3A4 inhibitors. The risk of stroke, intracranial bleeding and gastrointestinal bleeding